Urinary metabolomic characterization of meclofenoxate based on UHPLC-Q exactive HF orbitrap MS technology

The Analyst 2026

View at publisher
Authors: Bing Liu, Wennuo Xu, Tingyuan Zheng, Zhongquan Li, Jingjing Zhao
DOI: 10.1039/d5an01344e
Cited by: 0
References: 29

Abstract

This study demonstrated significant intergroup differences in the metabolites of urine samples before and after the administration of meclofenoxate and further screened for eight major potential biomarkers.

Fields of Study & Subjects

Metabolomics and Mass Spectrometry Studies Pharmacogenetics and Drug Metabolism Analytical Methods in Pharmaceuticals

Publication details

Journal / source
The Analyst
Volume
151
Issue
8
Pages
2372–2378
Publication date
1 January 2026
Language
EN